Evidence map›Paper›PMID 41142225›Full record

ArticleFrontiers in genetics2025

Case Report: Practical approach to differentiating juvenile parkinsonism of genetic cause and drug-induced parkinsonism in adolescents: a case series and literature review.

Ioana Grigore, Lăcrămioara Ionela Butnariu, Thomas Gabriel Schreiner, Vasile Valeriu Lupu, Ancuta Lupu, Ludmila Darie, Cătălin Prăzaru, Elena Țarcă, Setalia Popa, Ecaterina Grigore

Abstract readCase Reports
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ioana Grigore *Neurology, "St. Mary" Children Emergency Hospital, Iasi, Romania.
Lăcrămioara Ionela Butnariu *Department of Medical Genetics, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Thomas Gabriel SchreinerDepartment of Medical Specialties III, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Vasile Valeriu LupuDepartment of Pediatrics, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Ancuta LupuDepartment of Pediatrics, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Ludmila DarieNeurology, "St. Mary" Children Emergency Hospital, Iasi, Romania.
Cătălin PrăzaruNeurology, "St. Mary" Children Emergency Hospital, Iasi, Romania.
Elena ȚarcăDepartment of Surgery II-Pediatric Surgery, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Setalia PopaDepartment of Medical Genetics, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Ecaterina GrigoreFaculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile parkinsonism is a disease which is rarely seen in pediatric patients. In addition, drug-induced Parkinson's syndrome is generally rare in children; however, it represents one of the most severe iatrogenic movement disorders in adults. The authors present one case of genetically confirmed juvenile parkinsonism and two cases of chronic Parkinson's syndrome induced by psychiatric medication. The aim is to underline the differences between the clinical presentation, laboratory results, and the evolution under treatment. In addition, by reviewing literature data we analyzed the most significant information to describe the differences between these two conditions. Parkinsonian syndromes in pediatric patients and juvenile parkinsonism are difficult to diagnose based solely on clinical presentation because the manifestations are non-specific. Genetic testing and exclusion of other causes is essential for the final diagnosis. Adolescents who are diagnosed with drug-induced parkinsonian syndromes should undergo neurological evaluation, due to the fact that there is a risk of developing idiopathic Parkinson's disease later during adulthood.

Indexed as

adolescentsdrug-induced parkinsonian syndromeextrapyramidal syndromegenetic testingjuvenile parkinsonism

Identifiers

PMID41142225
PMCPMC12549009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.